Cargando…

Fibroblast activation protein-based theranostics in pancreatic cancer

Fibroblast activation protein-α (FAP) is a type II transmembrane serine protease that has specific endopeptidase activity. Given its well-established selective expression in the activated stromal fibroblasts of epithelial cancers, although not in quiescent fibroblasts, FAP has received substantial r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Chien-shan, Yang, Pei-wen, Sun, Yun, Song, Shao-li, Chen, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574192/ https://www.ncbi.nlm.nih.gov/pubmed/36263225 http://dx.doi.org/10.3389/fonc.2022.969731

Ejemplares similares

Prostate Cancer Theranostics - An Overview
por: Abou, Diane, et al.
Publicado: (2020)

The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma
por: Zhao, Guojie, et al.
Publicado: (2022)

Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review
por: Zhao, Liang, et al.
Publicado: (2022)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
por: Li, Rou, et al.
Publicado: (2021)

A Mouse Model of Damp-Heat Syndrome in Traditional Chinese Medicine and Its Impact on Pancreatic Tumor Growth
por: Jiao, Juying, et al.
Publicado: (2022)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management
por: Kuyumcu, Serkan, et al.
Publicado: (2021)

Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells
por: Zhang, Xianbin, et al.
Publicado: (2018)

Activated Pancreatic Stellate Cells Enhance the Warburg Effect to Cause the Malignant Development in Chronic Pancreatitis
por: Tao, Ye, et al.
Publicado: (2021)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
por: Yang, Ling, et al.
Publicado: (2019)

Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer
por: Zhong, Ailing, et al.
Publicado: (2020)

Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022)

Impacts of Activation of the Mitogen-Activated Protein Kinase Pathway in Pancreatic Cancer
por: Furukawa, Toru
Publicado: (2015)

Fibroblast Activation Protein Specific Optical Imaging in Non-Small Cell Lung Cancer
por: Mathieson, Layla, et al.
Publicado: (2022)

Preparation of Near-Infrared/Photoacoustic Dual-Mode Imaging and Photothermal/Chemo Synergistic Theranostic Nanoparticles and Their Imaging and Treating of Hepatic Carcinoma
por: Zhou, Yun, et al.
Publicado: (2021)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

Claudin and pancreatic cancer
por: Wang, Chen, et al.
Publicado: (2023)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy
por: Luo, Yong, et al.
Publicado: (2022)

Factors released by low and high-LET irradiated fibroblasts modulate migration and invasiveness of pancreatic cancer cells
por: Charalampopoulou, Alexandra, et al.
Publicado: (2022)

Prospects for Theranostics in Neurosurgical Imaging: Empowering Confocal Laser Endomicroscopy Diagnostics via Deep Learning
por: Izadyyazdanabadi, Mohammadhassan, et al.
Publicado: (2018)

Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics—Where We Are at and Where We Are Heading: A Systematic Review
por: Sidrak, Marko Magdi Abdou, et al.
Publicado: (2023)

Polyrotaxane-based supramolecular theranostics
por: Yu, Guocan, et al.
Publicado: (2018)

High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
por: Kesch, Claudia, et al.
Publicado: (2021)

PET/CT with Fibroblast Activation Protein Inhibitors in Breast Cancer: Diagnostic and Theranostic Application—A Literature Review
por: Taralli, Silvia, et al.
Publicado: (2023)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review
por: Xin, Lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lnkbofjhu9a8gnga33eq6670do